Abortion, Induced
32
0
0
25
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
9.4%
3 terminated out of 32 trials
89.3%
+2.8% vs benchmark
22%
7 trials in Phase 3/4
24%
6 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (32)
To Study the Safety and Efficacy of A Novel Intrauterine Estrogen-Releasing System in Induced Abortion
Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester Induction
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa
Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial
Paracervical Versus Intracervical Lidocaine
Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen
Dilapan-S / Dilasoft E-Registry in Induced Abortion
Same-day Long-acting Reversible Contraception for Medication Abortion
Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
Different Routes of Misoprostol Prior to First Trimester Surgical Abortion
Cervical Preparation Before Dilation and Evacuation
Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens
Misoprostol for Second Trimester Termination of Pregnancy
Intrauterine Lidocaine for Laminaria
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial
Cervical Priming Before Dilation & Evacuation